AI assistant
AstraZeneca Pharma India Ltd. — Board/Management Information 2024
Sep 25, 2024
60656_rns_2024-09-25_ca829285-bd95-42ba-ae2c-e2fde8e4fb19.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [521 x 87] intentionally omitted <==
September 25, 2024
The Manager – Listing BSE Limited 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001
The Manager – Listing National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051
Dear Sir(s),
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Ref: Scrip Code - BSE: 506820 / NSE: ASTRAZEN
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), we wish to inform the below:
-
Based on the recommendation of the Nomination & Remuneration Committee meeting, the Board of Directors have appointed Ms. Monica Widhani (DIN: 07674403) as an Additional Director (Independent) on the Board of the Company, with effect from September 25, 2024.
-
Mr. Narayan. K. Seshadri (DIN: 053563), Independent Director of the Company, will retire as Director of the Company upon completion of his term of office, at the close of business hours on September 29, 2024.
-
Ms. Shipla Divekar Nirula, Independent Director has been unanimously elected as Chairperson of the Board.
Dr. Sanjeev Panchal, Managing Director on behalf of the Board and the Company, would like to sincerely thank Mr. Narayan Seshadri for his significant contributions to the Company during his tenure as Director and Chairperson. Further, we would also like to congratulate Ms. Shilpa Divekar Nirula on her appointment as the new Chairperson of the Company and Ms. Monica on her appointment as an Additional Director on the Board of the Company.
Please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A.
Please take the same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Digitally signed MANAS by MANASA RAMA A RAMA Date: 2024.09.25 14:40:03 +05'30'
Manasa. R Company Secretary
==> picture [452 x 64] intentionally omitted <==
==> picture [521 x 87] intentionally omitted <==
Annexure - B
| Annexure - B | Annexure - B | ||
|---|---|---|---|
| Sl. | Particulars | Information about the change | |
| Retirement of Mr. Narayan. K. Seshadri |
Appointment of Ms. Monica Widhani |
||
| 1. | Reason for change viz. appointment, resignation, removal, death or otherwise |
Retirement of Mr. Narayan. K. Seshadri as a Director of the Company upon completion of his term of office. |
Appointment of Ms. Monica Widhani as an Additional Director (Independent) of the Company. |
| 2. | Date of appointment/cessation (as applicable) & term of appointment |
September 29, 2024 (cessation) | September 25, 2024 (appointment) |
| 3. | Brief profile (in case of appointment) |
- | Ms. Monica Widhani is has worked with Bharat Petroleum Corporation Limited (BPCL), India’s second largest oil marketing company. During her tenure of over 34 years with BPCL she has held various leadership positions in Aviation, Coordination, Retail Marketing, Retail Strategy, and Finance. These includes positions of Head of Retail Sales for North India, Head of Urban Retailing Strategy, Executive Director Coordination, and then as SBU Head of Aviation. Ms. Widhani has also held Board positions representing BPCL in its various Aviation Joint Ventures. She is currently also an Independent Director on the Board of ABB India Limited, Gujarat Pipavav Port Limited, HG Engineering Infra Limited, and Dreamfolks Services Limited. Ms. Monica Widhani is a Science Hons. Graduate and a qualified Chartered Accountant. She is the first woman Chartered Accountant in the state of Rajasthan and first woman Business Head for BPCL. |
| 4. | Disclosure of relationships between directors (in case of appointment of a Director) |
- | Neither related to any director on the Board of Directors of the Company nor with the promoter of the Company. |
| 5. | Affirmation pursuant to circular no. LIST/COMP/14/2018‐19 and circular no. NSE/CML/2018/02 dated June 20, 2018 issued by BSE and NSE |
- | Ms. Monica is not debarred from holding the office of Director by virtue of any SEBI Order or any such Authority. |
==> picture [452 x 64] intentionally omitted <==